Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.94
Delayed Data
As of Sep 28
 +0.04 / +2.11%
Today’s Change
1.23
Today|||52-Week Range
2.31
0.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues33.6M68.7M24.6M9.3M
 
 
 
 
 
Cost of Goods Sold17.4M47.1M2.5M0.00
 
 
 
 
Depreciation And Amortization3.0M2.4M1.1M--
 
 
 
 
 
Operating ExpensesGross Income13.2M19.2M21.0M9.3M
 
 
 
 
 
General Expenses29.9M25.1M29.2M34.3M
 
 
 
 
 
Research And Development18.1M15.1M19.8M26.3M
 
 
 
 
 
Total Operating Expenses50.3M74.6M32.8M34.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.7M-5.9M-8.2M-25.0M
 
 
 
 
 
Extraordinary Credit500.0K------
 
 
Extraordinary Charge0.00-4.2M-17.6M--
 
 
 
Interest Expense On Debt--0.00--300.0K
 
 
Other Expenses1.9M-1.4M6.6M-200.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.6M-11.3M-19.2M-25.4M
 
 
 
 
 
Income Taxes-100.0K-300.0K-100.0K0.00
 
 
 
 
Net Income-8.7M-11.0M-19.1M-25.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.2M31.3M35.4M38.6M
 
 
 
 
 
Shares To Calculate EPS Diluted28.2M31.3M35.4M38.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.35-$0.54-$0.66
 
 
 
 
 
EPS Diluted-$0.31-$0.35-$0.54-$0.66